The value of tissue polypeptide specific antigen TPS determination in serum of women with breast cancer comparison to mucin-like associated antigen MCA and CA 15-3 antigen

European Journal of Gynaecological Oncology

Volumn 19, Issue 5, 1998, Pages 503-507

  Kopczynski Z ^a   Thielemann, A ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Breast cancer; CA 15 3; MCA; TPS; Tumour markers

Indexed keywords

CA 15-3 ANTIGEN; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST DISEASE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POLAND; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOMA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0031725580     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Björklund B., Einarsson R.: "TPS (tissue polypeptide specific antigen) in oncologic practice: a review with reference to 3000 cases of breast cancer". Tumordiagn Ther., 1996, 17, 67.
2. Blijlevens N. M. A., Oosterhuis W. P., Oosten H. R., Mulder N. H.: "Clinical value of TPS, CEA and CA 15-3 in breast cancer patients". Anticancer Res., 1995, 15, 2711.
3. Bombardieri E., Gion M., Mione R., Dittadi R., Bruscagnin G., Burragi G.: "A mucinous-like carcinoma - associated antigen (MCA) in the tissue and blood of patients with primary breast cancer". Cancer, 1989, 63, 490.
4. Bonfrer J. M. G., Groenenveld Els. M., Korse C. M., van Dalen A., Oomen L. C. J., Ivanyi D.: "Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18". Tumor Biol., 1994, 15, 210.
5. Bremer K., Eklund G., Björklund B.: "Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer". Anticancer Res., 1996, 16, 905.
6. Cooper E. M., Forbes M. A., Hancock A. K., Price J. J., Parker D.: "An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer". Br. J. Cancer, 1989, 59, 797.
7. Einarsson R.: "TPS - a cytokeratin marker for therapy control in breast cancer". Scan. J. Clin. Lab. Invest., 1995, 221, 113.
8. Eskelinen M., Hippelainen M., Salmela E., Paajanen H., Alhava E., Syrjanen K.: "A prospective study of tissue polypeptide specific antigen (TPS) in breast cancer diagnosis". Anticancer Res., 1992, 12, 2033.
9. Giai M., Roagna R., Ponzone R., Biglia N., Sgro L., Perona M., Sismondi P.: "TPS and CA 15-3 serum values as a guide for treating and monitoring breast cancer patients". Anticancer Res., 1996, 16, 875.
10. Gion M., Mione R., Nascimben O., Valsecchi M., Gatti C., Leon A., Bruscagnin G.: "The tumor associated antigen CA 15-3 in primary breast cancer. Evaluation of 667 cases". Br. J. Cancer, 1991, 63, 809.
11. Howell D.: "Statistical methods for psychology". University of Vermont. Duxbury Press and imprint of wadswonh publishing company. Belmont. California 1992.
12. Koszarowski T., Gadomska H., Wronkowski Z., Romejko M.: "The study specification of malignant cancer in Poland in 1952-1982". (Polish text). Pol. Tyg. Lek., 1985, 35, 398.
13. Marczyńska A.: "Diagnostic value of biochemical markers determination in serum of patients with malignant cancer" (Polish text). Diagn. Lab., 1991, 27, 20.
14. Miserez A. R., Gunes I., Muller-Brond J., Walther E., Fridrich R., Macke H.: "Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3". Eur. J. Cancer, 1991, 27, 126.
15. O'Hanlon D. M., Kerin J. M., O'Boyle C., Grimes H., Giver H. F.: "Tissue polypeptide specific antigen (TPS) in breast cancer - an initial evaluation". Eur. J. Surg Oncol., 1996, 22, 38.
16. Padros A., Gratacos M., Pastor C., Barnandas A., Aguado A., Abad A.: "Tissue polypeptide specific antigen (TPS) and breast cancer. Symposium Three years with the proliferation marker TPS", Barcelona, 1993, February 4-6.
17. Safi F., Kohler I., Röttinger E., Beger M. G.: "The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer". Cancer, 1991, 68, 574.
18. Salman T., El-Ahmady O.: "The clinical value of serum TPS in gynecological malignances". Int. J. Biol. Marker, 1995, 10, 81.
19. Szymendera J. J , Géźdź S.: "The value of circulating tumor markers in diagnosis and management of cancer patients" (Polish text). Nowotwory, 1995, 45, 369.
20. van Dalen A : "How to integrate serum tumor markers into clinical oncologic practice". Nutrition, 1995, 11, 489.
21. Zatoński W., Tyczyński J.: "Malignant cancer in Poland in 1993" (Polish text). Institute of Epidemiology Cancer. National List of Cancer, Warszawa, 1996.